Revision history of "In vitro testing of biocompatibility of nanofibre biodegradable coverage releasing medicinal products" (Q10522)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 15:5815:58, 10 October 2024DG Regio talk contribs 53,098 bytes −2 Changed label, description and/or aliases in pt
  • curprev 15:5815:58, 10 October 2024DG Regio talk contribs 53,100 bytes +5 Set a claim value: summary (P836): Um problema constante da terapia anticancerígena é a inacessibilidade do tratamento imediato direcionado contra as células cancerosas, que podem permanecer no tecido após a ressecção. Uma maneira adequada de eliminar a regressão tumoral das células tumorais remanescentes parece ser a cobertura de tecido biodegradável de nanofibra que contém uma droga específica do tumor. O objetivo do projeto é a primeira fase de testes de cobertura, onde a citotoxi...

22 March 2024

15 January 2024

11 June 2023

17 February 2023

2 July 2022

  • curprev 13:0113:01, 2 July 2022DG Regio talk contribs 50,425 bytes +29,364 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et, cs, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, lt, lv, bg, hu, ga, sv, et,

15 January 2022

14 January 2022

12 December 2021

2 December 2021

  • curprev 08:0808:08, 2 December 2021DG Regio talk contribs 16,253 bytes +1,418 Created claim: summary (P836): Ein ständiges Problem der Krebstherapie ist die Nichtverfügbarkeit einer sofortigen Behandlung gegen Krebszellen, die nach der Resektionsoperation im Gewebe verbleiben können. Eine der geeigneten Möglichkeiten zur Beseitigung der Tumorregression aus dem Rest der Krebszellen ist eine nanofaserige biologisch abbaubare Gewebeabdeckung, die ein Tumor-spezifisches Medikament enthält. Ziel des Projekts ist die erste Phase der Abdeckungstests, in der d...
  • curprev 08:0808:08, 2 December 2021DG Regio talk contribs 14,835 bytes +163 Changed label, description and/or aliases in de: translated_label

28 November 2021

  • curprev 09:0709:07, 28 November 2021DG Regio talk contribs 14,672 bytes +1,491 Created claim: summary (P836): Un problème constant de traitement contre le cancer est l’indisponibilité d’un traitement immédiat ciblant les cellules cancéreuses, qui peuvent rester dans les tissus après une chirurgie de résection. L’un des moyens appropriés pour éliminer la régression tumorale du reste des cellules cancéreuses est une couverture tissulaire biodégradable nanofibre contenant un médicament spécifique à la tumeur. L’objectif du projet est la première phase des...
  • curprev 09:0709:07, 28 November 2021DG Regio talk contribs 13,181 bytes +156 Changed label, description and/or aliases in fr: translated_label

27 December 2020

28 October 2020

22 October 2020

  • curprev 15:1015:10, 22 October 2020DG Regio talk contribs 13,474 bytes +1,345 Created claim: summary (P836): A constant problem of anticancer therapy is the inaccessibility of immediate treatment targeted against cancer cells, which may remain in tissue after resection. One suitable way of eliminating tumor regression from the remaining tumor cells appears to be nanofiber biodegradable tissue coverage containing a tumor-specific drug. The aim of the project is the first phase of testing of covering, where cytotoxicity and the ability to activate immune...
  • curprev 15:1015:10, 22 October 2020DG Regio talk contribs 12,129 bytes −899 Removed claim: summary (P836): A permanent problem with cancer therapy is the lack of immediate treatment targeting cancer cells that can remain in tissue after the dissection procedure. One appropriate way of eliminating the regression of the cancer from the remaining tumour cells appears to be a potent biodegradable tissue cover containing the natord-specific medicinal product. The aim of the project is the first phase of coverage testing to verify cytotoxicity and the ab...
  • curprev 07:0607:06, 22 October 2020DG Regio talk contribs 13,028 bytes +161 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 07:0607:06, 22 October 2020DG Regio talk contribs 12,867 bytes −162 Changed label, description and/or aliases in 1 language: remove_english_label

15 July 2020

6 June 2020

25 March 2020

26 February 2020

  • curprev 07:4607:46, 26 February 2020DG Regio talk contribs 11,738 bytes +899 Created claim: summary (P836): A permanent problem with cancer therapy is the lack of immediate treatment targeting cancer cells that can remain in tissue after the dissection procedure. One appropriate way of eliminating the regression of the cancer from the remaining tumour cells appears to be a potent biodegradable tissue cover containing the natord-specific medicinal product. The aim of the project is the first phase of coverage testing to verify cytotoxicity and the abil...

17 February 2020

11 February 2020

6 February 2020

30 January 2020

28 January 2020

16 January 2020

10 January 2020